Starting of biological disease modifying antirheumatic drugs may be postponed in rheumatoid arthritis patients with multimorbidity: Single center real life results

The objective of this study was to assess the frequency of comorbidities and multimorbidities in rheumatoid arthritis (RA) patients under biologic therapy and their effects on biological disease modifying antirheumatic drugs (DMARDs) choice, timing, and response. Hacettepe University Biologic Regist...

Descripción completa

Detalles Bibliográficos
Autores principales: Armagan, Berkan, Sari, Alper, Erden, Abdulsamet, Kilic, Levent, Erdat, Efe Cem, Kilickap, Saadettin, Kiraz, Sedat, Bilgen, Sule Apras, Karadag, Omer, Akdogan, Ali, Ertenli, Ihsan, Kalyoncu, Umut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895384/
https://www.ncbi.nlm.nih.gov/pubmed/29595700
http://dx.doi.org/10.1097/MD.0000000000009930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895384/
https://www.ncbi.nlm.nih.gov/pubmed/29595700
http://dx.doi.org/10.1097/MD.0000000000009930

Ejemplares similares